Metaraminol Production Cost Reports

The report provides a detailed analysis essential for establishing a Metaraminol production plant. It encompasses all critical aspects necessary for Metaraminol production, including the cost of Metaraminol production, Metaraminol plant cost, Metaraminol production costs, and the overall Metaraminol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Metaraminol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Metaraminol is a medication that is used to treat low blood pressure (hypotension). It is utilised in spinal anaesthesia, shock, or after significant blood loss. It works mainly by narrowing blood vessels through stimulation of alpha-1 adrenergic receptors, which increases blood pressure by causing the vessels to constrict and improving the heart's pumping ability. It acts by releasing a natural chemical messenger that helps raise blood pressure. It is administered intravenously or intramuscularly and has a relatively quick onset of action. It is also used to treat priapism by injection into the penis to cause vasoconstriction. Its side effects include reflex slowing of the heart rate (bradycardia), arrhythmias, and excessive blood pressure elevation if used too frequently or in high doses.

The Metaraminol market is influenced by increasing demand for effective vasopressors to treat critical conditions like severe hypotension, septic shock, and blood pressure stabilisation during surgery or anaesthesia. The rising elderly population and the growing prevalence of cardiovascular diseases contribute to its market growth. Also, advances in critical care technology and expanding healthcare infrastructure globally fuel its demand. Factors like regulatory requirements for quality, sterility, and efficacy impact production and industrial Metaraminol procurement. Its sourcing is also affected by innovations in drug formulation and delivery methods, to reduce side effects and improve patient safety.

Raw Material for Metaraminol Production

According to the Metaraminol production plant project report, the key raw materials used in the production of Metaraminol include (m Hydroxybenzaldehyde)-Yeast/Fermentation Medium-Benzylamine.

Production Process of Metaraminol

The extensive Metaraminol production cost report consists of the following major industrial production process:

1. From m Hydroxybenzaldehyde: The production process of Metaraminol involves fermentation of m hydroxybenzaldehyde with yeast in an aqueous sugar medium that leads to the formation of m (hydroxyphenyl)acetyl carbinol.  This intermediate is condensed with benzylamine to generate the corresponding imine under. After that, the imine is catalytically hydrogenated over Pd/C to get metaraminol free base. This converts the base metaraminol to active API for the formation of the drug.

Metaraminol has a molecular formula of C9H13NO2 and a molecular weight of around 167.2 g/mol. It has two chiral centres and a benzene ring in its structure. It shows good water solubility and has a melting point near 107.5 degree Celsius. The compound has a low octanol/water partition coefficient (LogP) of about -0.27, which makes it more hydrophilic. It appears as a solid powder and forms clear, colourless solutions when dissolved. Its structure includes a hydroxyl group on the phenol ring and an alpha-carbon substituted amine with specific stereochemistry important for its biological activity. It has rotatable bonds and hydrogen bond donors and acceptors contributing to its interaction with receptor sites. All these physical and chemical properties make it useful as an α1-adrenergic receptor agonist producing peripheral vasoconstriction, which helps in increasing blood pressure.